arsenic trioxide has been researched along with Cancer of Prostate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aghamir, SMK; Akbari, MR; Khatami, F; Mirzaei, A; Rashedi, S | 1 |
| Jiang, T; Li, QL; Peng, JQ; Su, XM; Sun, DC; Zhang, ZW; Zheng, L | 1 |
| Ji, H; Jiang, F; Li, Y; Shen, J; Wang, X; Yang, X; Zhang, J | 1 |
| Bhatt, P; Jadhav, V; Ray, P; Sachdeva, G | 1 |
| Liang, C; Tai, S; Xu, L; Xu, M; Zhang, K; Zhang, L; Zhang, Y | 1 |
| Burnstein, KL; Rosenblatt, AE | 1 |
| Chen, L; Dong, Z; Meng, Q; Peng, Z; Si, J; Xia, Y | 1 |
| Chen, YA; Chiu, HW; Ho, SY; Wang, YJ | 1 |
| Alhasan, MK; Lewis, MA; Liu, L; Magnusson, J; Mason, RP | 1 |
| Cohen, FJ; Gui, D; Ikezoe, T; Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW; Tong, XJ | 1 |
| Hori, S; Kakehi, Y; Kakizuka, A; Maeda, H; Ogawa, O; Ohizumi, H; Segawa, T | 1 |
| Jing, Y; Lu, M; Luo, D; Waxman, S; Xia, L | 1 |
| Jiang, H; Jiang, T; Wang, Y | 1 |
| Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Sezgin, C; Terzioglu, E; Uslu, R | 1 |
| Hori, S; Ichijo, H; Kakehi, Y; Kakizuka, A; Maeda, H; Nishitoh, H; Ogawa, O | 1 |
15 other study(ies) available for arsenic trioxide and Cancer of Prostate
| Article | Year |
|---|---|
Combined anticancer effects of simvastatin and arsenic trioxide on prostate cancer cell lines via downregulation of the VEGF and OPN isoforms genes.
Topics: Apoptosis; Arsenic Trioxide; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prostatic Neoplasms; Protein Isoforms; Simvastatin; Vascular Endothelial Growth Factor A | 2022 |
[Arsenic trioxide induces the apoptosis of prostate cancer PC-3 cells via the P38 signaling pathway].
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Humans; Male; MAP Kinase Signaling System; Oxides; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Signal Transduction | 2013 |
Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer.
Topics: Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Male; MicroRNAs; Oxides; Prostatic Neoplasms; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |
Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biocompatible Materials; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Epigenesis, Genetic; Humans; Male; Metal Nanoparticles; Oxides; Prostatic Neoplasms | 2016 |
Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Beclin-1; Cell Line, Tumor; Drug Synergism; Everolimus; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Male; Mice, SCID; Microscopy, Fluorescence; Microtubule-Associated Proteins; Oxides; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2017 |
Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Nucleus; Cell Proliferation; Drug Evaluation, Preclinical; Drug Synergism; Humans; Male; Nitriles; Nuclear Receptor Coactivator 2; Oxides; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein Transport; Receptors, Androgen; Response Elements; Tosyl Compounds; Transcriptional Activation; Tumor Cells, Cultured | 2009 |
Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells.
Topics: Animals; Arsenic Trioxide; Arsenicals; Glutathione; Humans; Leukemia; Male; Mice; NF-kappa B; Oxidative Stress; Oxides; Prostatic Neoplasms; Signal Transduction | 2010 |
Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells.
Topics: Androgens; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Body Weight; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Therapy, Combination; Humans; Male; Mice; Mice, Nude; Oxides; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Radiation, Ionizing; Signal Transduction; Time Factors; Tumor Burden | 2012 |
Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Vessels; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Optical Imaging; Oxides; Prostatic Neoplasms; Ultrasonography, Doppler | 2012 |
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by
Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome | 2004 |
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oxides; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2004 |
Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Oxides; Prostatic Neoplasms | 2004 |
[Experimental research on the effect of arsenic trioxide on the growth of prostate cancer PC-3 cell lines].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Male; Oxides; Prostatic Neoplasms | 2004 |
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Carcinogens; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Oxides; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Death; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred BALB C; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Oxides; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2001 |